<DOC>
	<DOCNO>NCT02338453</DOCNO>
	<brief_summary>This RCT examine effectiveness Attention Bias Modification Treatment ( ABMT ) augment Cognitive-Behavioral Group Treatment ( CBGT ) Social Anxiety Disorder ( SAD ) adult . It expect ABMT vs. control training condition would achieve well therapeutic outcome indicate reduction symptom .</brief_summary>
	<brief_title>Attention Bias Modification Treatment ( ABMT ) Cognitive-Behavioral Group Therapy ( CBGT ) Social Anxiety Disorder</brief_title>
	<detailed_description>Outpatients seek treatment Social Anxiety Disorder ( SAD ) Geha anxiety-disorders clinic randomize two group ( ABMT+CBGT ; placebo control+CBGT ) . One group undergo Attention Bias Modification Treatment ( ABMT ) aim divert attention away socially-threatening stimulus . The second group receive placebo-control design affect attention . Both group also undergo standard Cognitive-Behavioral Group Treatment ( CBGT ) comprise 18 weekly session 1.5-hr duration ( along line Heimberg , Juster , Hope &amp; Mattia 1995 Clark &amp; Wells 1995 ) . Symptoms attention bias measure take three time point : Pre-treatment , Post-treatment , 3-month follow-up . The study include follow step : ) initial assessment participant ' psychopathology symptom level ; b ) attention bias measurement ; c ) 8 session ABMT/placebo control deliver part CBGT session ; ) two booster ABMT/Placebo treatment deliver session 13 16 CBGT protocol . e ) post-treatment assessment include symptom attention bias assessment . Finally , f ) three-month follow assessment . The goal study test effectiveness ABMT add-on establish CBGT protocol social anxiety disorder .</detailed_description>
	<mesh_term>Disease</mesh_term>
	<mesh_term>Anxiety Disorders</mesh_term>
	<mesh_term>Phobic Disorders</mesh_term>
	<criteria>A signed consent form Men woman age 18 60 . Meeting current diagnosis Social Anxiety Disorder ( SP ) accord DSMIV A minimum 1year duration SP SP primary diagnosis : In case comorbidity , SP deem distress clinically significant condition among comorbid disorder Stable pharmacotherapy : Participants receive pharmacological treatment take stable medication least 3 month begin CBGT . Psychotic episode past present time . Comorbidity neurological disorder ( i.e. , epilepsy , brain injury ) . Another psychotherapeutic treatment study . Usage neuroleptic medication . Change medication status study . Substantial usage drug alcohol present time . Poor judgment capacity ( i.e. , child 18 special population ) .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Social Anxiety</keyword>
	<keyword>Attention Modification</keyword>
	<keyword>Dot-Probe</keyword>
	<keyword>GCBT</keyword>
</DOC>